Ergomed Makes Board Changes, Names CEO For Subsidiary
This article was originally published in Scrip
Ergomed plc, a UK-based company focused on specialized services for the pharmaceutical industry and the development of new drugs, has named current chief financial officer, Neil Clark, full time CEO of Ergomed's trading subsidiary PrimeVigilance, a drug safety and medical information business. Clark will remain an Ergomed board member.
Register for our free email digests: